# Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts at Tertiary Care Hospital in Karachi.

> **NCT06821594** · EARLY_PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Jinnah Postgraduate Medical Centre** · enrollment: 40 (estimated)

## Conditions studied

- Cutaneous Warts

## Interventions

- **DRUG:** Furosemide

## Key facts

- **NCT ID:** NCT06821594
- **Lead sponsor:** Jinnah Postgraduate Medical Centre
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-04-01
- **Primary completion:** 2025-08-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06821594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06821594, "Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts at Tertiary Care Hospital in Karachi.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06821594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*